These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 9484863
1. Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium. Demontis MP, Varoni MV, Volpe AR, Emanueli C, Madeddu P. Br J Pharmacol; 1998 Jan; 123(1):129-35. PubMed ID: 9484863 [Abstract] [Full Text] [Related]
2. Cardiovascular regulation by L-arginine in the brain of rats: role of the brain renin-angiotensin system and nitric oxide. Nishimura M, Takahashi H, Nanbu A, Sakamoto M, Yoshimura M. Am J Hypertens; 1997 Apr; 10(4 Pt 1):389-96. PubMed ID: 9128204 [Abstract] [Full Text] [Related]
3. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats. Reis WL, Giusti-Paiva A, Ventura RR, Margatho LO, Gomes DA, Elias LL, Antunes-Rodrigues J. Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344 [Abstract] [Full Text] [Related]
4. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts. Kojda G, Kottenberg K, Stasch JP, Schrör K, Noack E. Br J Pharmacol; 1997 Nov; 122(5):813-20. PubMed ID: 9384495 [Abstract] [Full Text] [Related]
5. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats. Sacco G, Evangelista S, Criscuoli M, Goso C, Bigioni M, Binaschi M, Manzini S, Maggi CA. Eur J Pharmacol; 2005 Mar 28; 511(2-3):167-74. PubMed ID: 15792785 [Abstract] [Full Text] [Related]
6. Central inhibition of nitric oxide synthesis increases blood pressure and heart rate in anesthetized rats. Nurminen ML, Ylikorkala A, Vapaatalo H. Methods Find Exp Clin Pharmacol; 1997 Mar 28; 19(1):35-41. PubMed ID: 9098838 [Abstract] [Full Text] [Related]
7. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR. Br J Pharmacol; 1997 Dec 28; 122(8):1617-24. PubMed ID: 9422806 [Abstract] [Full Text] [Related]
8. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW. Br J Pharmacol; 1997 Dec 28; 122(7):1441-9. PubMed ID: 9421293 [Abstract] [Full Text] [Related]
9. [Chronic and acute effect of cycletanine in NO-dependent hypertensive pregnant rats]. Van Overloop B, Pernot F, Dité C, Droy-Lefaix MT, Gairard A. Arch Mal Coeur Vaiss; 1995 Aug 28; 88(8):1223-7. PubMed ID: 8572878 [Abstract] [Full Text] [Related]
10. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats. Maeda T, Yoshimura T, Ohshige A, Koyama H, Ito M, Okamura H. Artery; 1998 Aug 28; 23(1):1-9. PubMed ID: 10846613 [Abstract] [Full Text] [Related]
11. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK, Rivier C. J Neuroendocrinol; 1998 May 28; 10(5):353-62. PubMed ID: 9663649 [Abstract] [Full Text] [Related]
12. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase. Kiss A, Jurkovicova D, Jezova D, Krizanova O. Endocr Regul; 2001 Jun 28; 35(2):65-70. PubMed ID: 11563933 [Abstract] [Full Text] [Related]
13. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats. McKendrick JD, Salas E, Dubé GP, Murat J, Russell JC, Radomski MW. Br J Pharmacol; 1998 May 28; 124(2):361-9. PubMed ID: 9641554 [Abstract] [Full Text] [Related]
14. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. du Toit EF, McCarthy J, Miyashiro J, Opie LH, Brunner F. Br J Pharmacol; 1998 Mar 28; 123(6):1159-67. PubMed ID: 9559900 [Abstract] [Full Text] [Related]
15. Tuning adenosine A1 and A2A receptors activation mediates L-citrulline-induced inhibition of [3H]-acetylcholine release depending on nerve stimulation pattern. Timóteo MA, Oliveira L, Campesatto-Mella E, Barroso A, Silva C, Magalhães-Cardoso MT, Alves-do-Prado W, Correia-de-Sá P. Neurochem Int; 2008 Mar 28; 52(4-5):834-45. PubMed ID: 18022291 [Abstract] [Full Text] [Related]
16. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Savci V, Cavun S, Goktalay G, Ulus IH. Naunyn Schmiedebergs Arch Pharmacol; 2002 May 28; 365(5):388-98. PubMed ID: 12012025 [Abstract] [Full Text] [Related]
17. Effects of L-NAME and L-Arg on arterial blood pressure in normotensive and hypertensive streptozotocin diabetic rats. Costa MA, Balaszczuk AM, Domínguez A, Catanzaro O, Arranz C. Acta Physiol Pharmacol Ther Latinoam; 1998 May 28; 48(2):59-63. PubMed ID: 9695876 [Abstract] [Full Text] [Related]
18. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline. Lee TJ, Sarwinski S, Ishine T, Lai CC, Chen FY. J Pharmacol Exp Ther; 1996 Feb 28; 276(2):353-8. PubMed ID: 8632296 [Abstract] [Full Text] [Related]
19. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E. Eur J Pharmacol; 2007 Oct 01; 571(2-3):189-96. PubMed ID: 17610863 [Abstract] [Full Text] [Related]